Evidence map›Paper›PMID 41240952›Full record

ArticleThe Lancet. Global health2025

Effect of malaria chemoprevention for school-age children across transmission archetypes: a modelling study.

Joshua Suresh, Marita Zimmermann, Catherine Maiteki, Anne Stahlfeld, Abigail Pratt, Don P Mathanga, Sarah G Staedke, Miriam K Laufer, Chris Drakeley, Caitlin Bever and 1 more

Abstract read
In one paragraph

Article in The Lancet. Global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Joshua SureshInstitute for Disease Modeling, Gates Foundation, Seattle, WA, USA. Electronic address: josh.suresh@gatesfoundation.org.
Marita ZimmermannInstitute for Disease Modeling, Gates Foundation, Seattle, WA, USA.
Catherine MaitekiMinistry of Health, Kampala, Uganda.
Anne StahlfeldThe Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Abigail PrattGates Foundation, Seattle, WA, USA.
Don P MathangaMalaria Alert Centre, Kamuzu University of Health Sciences, Blantyre, Malawi.
Sarah G StaedkeLiverpool School of Tropical Medicine, Liverpool, UK.
Miriam K LauferCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Chris DrakeleyLondon School of Hygiene and Tropical Medicine, London, UK.
Caitlin BeverInstitute for Disease Modeling, Gates Foundation, Seattle, WA, USA.
Lauren M CoheeLiverpool School of Tropical Medicine, Liverpool, UK; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Funding

Mentoring in patient-oriented research in global healthK24AI114996 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LAUFER, MIRIAM K. · 2016 to 2025
$1.6M
Impact of P. falciparum diversity on transmission reducing immunityK23AI135076 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI COHEE, LAUREN M · 2018 to 2022
$940k
NIAID NIH HHS K23 AI135076NIAID NIH HHS K24 AI114996
6 · The paper itself

Abstract

backgroundIntermittent preventive treatment (IPT) of school-aged children with antimalarial drugs decreases rates of infection, anaemia, and clinical malaria. Since school-aged children are a major transmission reservoir, we estimated the effect of IPT for this group on Plasmodium falciparum transmission to younger children and adults across three epidemiological settings.

methodsWith the use of an established malaria transmission model, we developed three epidemiological archetypes (Sahelian, Central, and Southern African) and estimated the effect of IPT of school-age children across transmission levels (P falciparum parasite rate in children aged 2-10 years [PfPR

findingsWhen long-acting drugs were administered frequently (monthly campaigns with dihydroartemisinin-piperaquine), modelled IPT of school-age children averted 70-90% of cases in school-aged children (up to about 2·0 cases per child per year) and 20-60% of cases in younger children and adults (up to about 0·5 cases per person per year), with greater community benefit at lower transmission levels (PfPR

interpretationOur model suggests that adding IPT of school-age children to current control tools could decrease malaria burden in this group and reduce P falciparum transmission.

fundingUS National Institutes of Health, Doris Duke Clinical Scientist Development Award.

Indexed as

AntimalarialsChemopreventionMalaria, FalciparumAdultAmodiaquineArtemisininsChildChild, PreschoolDrug CombinationsFemaleHumansMaleModels, TheoreticalPiperazinesPlasmodium falciparumPyrimethamineAmodiaquineAntimalarialsArtemisininsartenimolDrug Combinationsfanasil, pyrimethamine drug combinationpiperaquinePiperazinesPyrimethamineQuinolinesSulfadoxine

Identifiers

PMID41240952
PMCPMC12621301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.